{
    "2021-09-26": [
        [
            {
                "time": "",
                "original_text": "抗Delta表现优异，沃森疫苗部分临床数据流出，国产mRNA新冠疫苗竞速",
                "features": {
                    "keywords": [
                        "Delta",
                        "沃森",
                        "疫苗",
                        "临床数据",
                        "mRNA",
                        "新冠"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物技术"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物(300142.SZ)：刘俊辉及其配偶黄静合计持股比例被动降低至5%以下",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "刘俊辉",
                        "黄静",
                        "持股比例",
                        "被动降低"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：海外新冠治疗药物有望Q4陆续获批 重点推荐相关CDMO标的",
                "features": {
                    "keywords": [
                        "医药生物",
                        "新冠治疗药物",
                        "Q4",
                        "获批",
                        "CDMO"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物技术"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业资金流入榜：6股净流入资金超亿元",
                "features": {
                    "keywords": [
                        "医药生物",
                        "资金流入",
                        "净流入"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物技术"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}